Detalhe da pesquisa
1.
Magnetic resonance linear accelerator technology and adaptive radiation therapy: An overview for clinicians.
CA Cancer J Clin
; 72(1): 34-56, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34792808
2.
Adding 6 months of androgen deprivation therapy to postoperative radiotherapy for prostate cancer: a comparison of short-course versus no androgen deprivation therapy in the RADICALS-HD randomised controlled trial.
Lancet
; 403(10442): 2405-2415, 2024 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-38763154
3.
Stereotactic body radiotherapy for primary renal cell carcinoma: a systematic review and practice guideline from the International Society of Stereotactic Radiosurgery (ISRS).
Lancet Oncol
; 25(1): e18-e28, 2024 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-38181809
4.
Delphi consensus on stereotactic ablative radiotherapy for oligometastatic and oligoprogressive renal cell carcinoma-a European Society for Radiotherapy and Oncology study endorsed by the European Association of Urology.
Lancet Oncol
; 25(5): e193-e204, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38697165
5.
Focal radiotherapy boost to MR-visible tumor for prostate cancer: a systematic review.
World J Urol
; 42(1): 56, 2024 Jan 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-38244059
6.
Impact of centralization of prostate cancer services on the choice of radical treatment.
BJU Int
; 131(1): 53-62, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35726400
7.
Intensity-modulated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): 2-year toxicity results from an open-label, randomised, phase 3, non-inferiority trial.
Lancet Oncol
; 23(10): 1308-1320, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36113498
8.
Long-term multicentre experience of adjuvant radiotherapy for pN3 squamous cell carcinoma of the penis.
BJU Int
; 128(4): 451-459, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249744
9.
The Emerging Role of Local Therapy in Metastatic Prostate Cancer.
Curr Oncol Rep
; 22(1): 2, 2020 01 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-31960153
10.
Intensity-modulated fractionated radiotherapy versus stereotactic body radiotherapy for prostate cancer (PACE-B): acute toxicity findings from an international, randomised, open-label, phase 3, non-inferiority trial.
Lancet Oncol
; 20(11): 1531-1543, 2019 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-31540791
11.
Impact of Ga-68-PSMA PET/CT on management in prostate cancer patients with very early biochemical recurrence after radical prostatectomy.
Eur J Nucl Med Mol Imaging
; 46(4): 901-907, 2019 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-30617554
12.
Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer.
World J Urol
; 37(12): 2615-2621, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31346760
13.
Trends in Management of Oligometastatic Hormone-Sensitive Prostate Cancer.
Curr Oncol Rep
; 21(5): 43, 2019 03 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30919165
14.
Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI.
J Appl Clin Med Phys
; 20(3): 27-36, 2019 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-30756456
15.
The Role of Hypofractionated Radiotherapy in Prostate Cancer.
Curr Oncol Rep
; 19(4): 30, 2017 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-28343352
16.
Should stereotactic radiotherapy be the preferred treatment for oligometastatic disease?
Lancet Oncol
; 22(8): 1067-1068, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34339642
17.
Intermediate clinical endpoints in localised prostate cancer.
Lancet Oncol
; 22(3): 294-296, 2021 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-33662281
18.
Considering benefit and risk before routinely recommending SpaceOAR.
Lancet Oncol
; 22(1): 11-13, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33387489
19.
The delineation of intraprostatic boost regions for radiotherapy using multimodality imaging.
Future Oncol
; 12(21): 2495-2511, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27322113
20.
Optimal patient selection for stereotactic body radiotherapy - Authors' reply.
Lancet Oncol
; 20(12): e662, 2019 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-31797788